NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market Wednesday that its fourth-quarter revenues increased 32 percent to $1.1 million from $868,000, beating the consensus Wall Street estimate for revenues of $900,000.

The firm's product sales were $1 million for the three months ended Dec. 31, 2012, compared to $755,000 for the fourth quarter of 2011. License revenues were flat year over year at $113,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.